SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-100392
Filing Date
2011-04-18
Accepted
2011-04-18 08:34:33
Documents
8
Period of Report
2011-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26166
2 PLACEMENT AGENT AGREEMENT dex11.htm EX-1.1 158184
3 FORM OF COMMON STOCK PURCHASE WARRANT dex41.htm EX-4.1 71461
4 OPINION OF COOLEY LLP dex51.htm EX-5.1 9329
5 FORM OF SUBSCRIPTION AGREEMENT dex101.htm EX-10.1 156423
6 PRESS RELEASE dex991.htm EX-99.1 7670
7 GRAPHIC g174587ex5_1.jpg GRAPHIC 6565
8 GRAPHIC g174587g76m24.jpg GRAPHIC 3443
  Complete submission text file 0001193125-11-100392.txt   444633
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 11764433
SIC: 2835 In Vitro & In Vivo Diagnostic Substances